• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
qPCR and dPCR Instrumentation - Global Strategic Business Report Product Image

qPCR and dPCR Instrumentation - Global Strategic Business Report

  • ID: 2707968
  • February 2015
  • Region: Global
  • 288 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousands by the following Product Segments: qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction). Also, the report analyzes the following End-Uses: Educational/Research, Testing Laboratories, Pharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

Company profiles are primarily based on public domain information including company URLs. The report profiles 41 companies including many key and niche players such as:

- Agilent Technologies, Inc.
- Becton, Dickinson and Company
- BioFire Diagnostics, Inc.
- Bio-Rad Laboratories, Inc.
- Cepheid

Note: Product cover images may vary from those shown

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of the Study
qPCR
dPCR

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW
Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification
Striking the Right Balance between qPCR and dPCR in Research Laboratories
qPCR- A Suitable Tool for Gene Expression and Validation
Select qPCR Systems Available in Marketplace
Thermo Fisher Life Sciences Prism 7000 Series
Thermo Fisher Life Sciences ViiA 7
Thermo Fisher Life Sciences QuantStudio
Cepheid SmartCycler Platform
Roche LightCycler Platform
Roche FLOW
As qPCR Technology Matures, Saturation is Imminent
Table 1: Global qPCR Instrumentation Market by Category (2014): Percentage Share Breakdown of Annual Revenues for Reagents and Instruments (includes corresponding Graph/Chart)
Digital PCR Holds Potential to Take Quantification of Nucleic Acids to the Next Level
Despite Onslaught of Digital PCR, qPCR Maintains Relevance
dPCR
A Valuable Tool in Virology Research
High Sensitivity in Viral Detection
Table 2: World PCR Market for Clinical Diagnosis of Infectious Diseases by Type of Disease (2014): Percentage Market Share Breakdown for Hepatitis B & Hepatitis C Test, Tuberculosis Diagnosis, HIV Diagnosis, and Others (includes corresponding Graph/Chart)
Table 3: Worldwide PCR Market for Clinical Diagnosis of Non-Infectious Diseases by Type of Disease (2014): Percentage Market Share Breakdown for Hepatitis B & Hepatitis C Test, Tuberculosis Diagnosis, HIV Diagnosis, and Others (includes corresponding Graph/Chart)
Creation and Validation of Viral Reference Standards
High-Precision Quantification
Digital PCR Sales to Skyrocket in the Near Term
New dPCR Systems to Capture a Bigger Slice of the Overall PCR Market
Table 4: Leading dPCR Systems at a Glance
QuantStudio 3D Digital PCR System
QuantStudio 12K
BioMark HD system
QX100 droplet digital PCR System
RainDrop Systems
High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR
Table 5: Price Range of Select PCR Equipment of Thermo Fisher Life Sciences Solutions

2. GROWTH DRIVERS, MARKET TRENDS & ISSUES
Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR
Table 6: Worldwide Incidence of Cancer (2013, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)
Table 7: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 8: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 9: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 10: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 11: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 12: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests
Table 13: Per-Capita Healthcare Expenditure in Select Regions: 2014E (includes corresponding Graph/Chart)
Progress in Human Genome Project and Molecular Diagnostics Spur Demand for the Gene Amplification Technologies
Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter
Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies
qPCR and NGS to Drive Single-Cell Genomics Market
Advancements in Probe Technology Enhance qPCR Sensitivity
qPCR Market to Witness increasing Affinity for Automated and Robotic Equipment
Factors influencing Selection of Lab Robots
Lab on Chip/Microfluidic Real-time-PCR- A Game Changer in the Offing
Two Types of Microfluidic Designs
Advantages of Lab on Chip PCR
Roadblocks in the Path to Development
New Developments in Lab-on-chip PCR
Droplet digital PCR Finds Increasing Application in Life Sciences Research
ddPCR gains Traction in Cancer Diagnosis
Monitoring Disease Progression in HIV Studies
Analysis of Genetically Modified Organisms in Edible Products
RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples
Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines
Alternate Technologies Pose Threat to Growth of PCR Market
New Isothermal PCR Technology
A Potential Game Changer Promising Faster PCR

3. COMPETITION
Table 14: Global qPCR Instruments Market by Leading Player (2014): Percentage Market Share Breakdown of Value Sales for Life Sciences Research for Thermo Fisher Life Sciences, Bio-Rad, Roche, Agilent, Qiagen, and Others (includes corresponding Graph/Chart)
Select qPCR Products by Company
Thermo Fisher Life Sciences Solutions
The Leading Player
Table 15: PCR Systems Product Portfolio of Thermo Fisher Life Sciences Solutions
Patent Expiries Impact Royalty Revenues Inflow of Thermo Fisher Life Sciences
Table 16: Life Technologies’ Royalty Roll-Off by Year: 2009-2013 (includes corresponding Graph/Chart)
Cost of PCR instruments and Reagents to Decline
Competition Heats Up in dPCR Market
Intense Competition Triggers a Spate of M&A
Manufacturers Step-Up Online Exposure
Multiple Factors to Sustain Consolidation Trend in PCR Industry
Accelerated Commercialization of Products
Offering Integrated and Multi-technology Solutions
Manufacturers Target Expansion of Distribution Reach and Global Footprint

4. END-USE MARKET ANALYSIS
Application Areas of PCR
Medical and Diagnostics
PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
Detection of Antimicrobial Resistance
PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents
Forensic and Paternity Testing
Food Safety
Detection and Quantification of Food Pathogens
Detection of Beneficial and Non-Pathogenic Microbes
Study of Microbial Responses to Environment
Microbial Risk Assessment
qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate
PCR Technique in Identification of GMOs
Research & Academics
SYBR Dye and TaqMan Techniques Popular in Research Publications

5. PRODUCT OVERVIEW
Introduction to Polymerase Chain Reaction (PCR)
Reagents and Components Required for PCR
Reaction Steps
Denaturation
Annealing
Extension
Real-Time PCR or Quantitative PCR (qPCR)
qPCR Instrumentation
Evolution
Working of qPCR Instruments
Thermal Control
Fluorimetry
DNA Detection Methods
Fluorescence Measurement
Asymmetrical dsDNA dyes
Quantification
High-Throughput qPCR
Comparison of Working of Conventional PCR versus qPCR
Drawbacks in Core PCR
Advantages of qPCR
Disadvantages of qPCR
End-Use Applications of qPCR
Factors Influencing Purchase Decisions of qPCR Systems
qPCR Consumables, Accessories and Software
DIGITAL PCR
Development of dPCR
Working Principle
Droplet dPCR
Applications of dPCR
Advantages of dPCR

6. INSIGHT INTO GLOBAL SPENDING ON LIFE SCIENCES RESEARCH
Global Life Sciences Research and Development Landscape
Table 17: Select Countries with R&D Spending as a % of GDP: 2014 (includes corresponding Graph/Chart)
Sequestration Bites Deep into US Research Funds
Table 18: NIH Annual Appropriations in US$ Billions, and RPG Funding (2008-2014) (includes corresponding Graph/Chart)
Table 19: NCI Research Spending in US$ Millions on Major Types of Cancers Listed in Decreasing Order of Prevalence (2010, 2011, 2012 & 2013) (includes corresponding Graph/Chart)
New MoPath Codes for Reimbursement for Medical Diagnostics Tests
Government Takes Major Steps to Revive Japan Life Sciences Sector
Table 20: Human Frontier Science Program Budget for 2014 by Country: Contribution in US$ Million for Japan, United States, European Union, and Others (includes corresponding Graph/Chart)
Table 21: Japanese Government Stimulus Package for Life Sciences Sector: 2013 (includes corresponding Graph/Chart)
Fiscal Prudence to Undermines Research Programs
Table 22: European Research Council (ERC) Funding for Life Sciences by Country (2008-2013): Breakdown of Number of Starting Grants Allocated for United Kingdom, Germany, France, Israel, Switzerland, Netherlands, Sweden, Spain, Belgium, Austria, and Others (includes corresponding Graph/Chart)
Table 23: European Research Council (ERC) Funding for Life Sciences by Country (2008-2013): Breakdown of Number of Advance Grants Allocated for United Kingdom, Germany, France, Switzerland, Netherlands, Italy, Israel, Spain, Sweden, Belgium, and Others (includes corresponding Graph/Chart)
Asia Pacific
The New Global Hub for Life Sciences Research

7. PRODUCT INNOVATIONS/INTRODUCTIONS
Agilent Technologies Launches AriaMx System
Life Technologies Launches QuantStudio 3D Digital PCR System
LGC Introduces Updated 1536-Well PCR Plate for Genomics Applications
Exiqon Unveils Toxicology Focus microRNA PCR Panel
Exiqon Introduces LNA™ LongRNA GapmeR Products
Life Technologies and Quidel Secure US FDA Approval for Marketing qPCR Instruments
Life Technologies Obtains US FDA Approval for 3500 Dx Genetic Analyzers and SeCore® HLA Typing Kit
Bio-Rad Laboratories Unveils QX200 ddPCR System
Exiqon Introduces Customized qPCR Arrays
Life Technologies Provides QuantStudio 3D Digital PCR System to Five Research Labs
Bio-Rad Unveils iTaq Universal Supermixes
Nextreme Thermal Solutions Introduces New-Generation Reference Design for Compact PCR Thermal Cycler
Sigma Life Science Introduces KiCqStart Primers
Bio-Rad Rolls Out CFX96 Touch Deep Well PCR Detection System
Roche Introduces Light Cycler 96 System
Fluidigm Rolls Out New Integrated Fluidic Circuits
Promega Unveils GoTaq Master Mixes Range
Illumina Unveils Real-Time PCR Reagent Portfolio
Integromics® Introduces OmicsOffice® Platform
Ingenuity Systems and Life Technologies Unveil Ingenuity iReport for Real-Time PCR
Life Technologies Introduces QuantStudio™ Dx Real-Time PCR Instrument
RainDance Technologies Introduces RainDrop™ Digital PCR Platform
Life Technologies Unveils QuantStudio 3D Digital PCR System Chip-Based Instrument
Integromics® Unveils RealTime StatMiner® 4.3 on TIBCO® Spotfire®
Bio-Rad Laboratories Unveils CFX Qualification Plate
Exiqon Unveils miRCURY™ RNA Isolation Kit-Biofluids
Bio-Rad Laboratories Launches One-Step RT-ddPCR Kit
Accelero® Bioanalytics Announces Addition of RT-qPCR System of Applied Biosystems

8. RECENT INDUSTRY ACTIVITY
Thermo Fisher Scientific Completes Take Over of Life Technologies
Quotient Bioresearch Divests Bioanalytical Sciences Business to LGC
Thermo Fisher Scientific Inks Definitive Agreement to Take Over Life Technologies
QIAGEN and WaferGen Bio-systems Ink Co-Marketing Agreement
Biodesign Institute® Enters into Partnership with Life Technologies
WaferGen Bio-systems Enters into Partnership with Salk Institute to Establish nano-qPCR Core Laboratory
TATAA Biocenter Extends Product Line
Integrated DNA Technologies to Showcase Novel Multiplex qPCR Assays
Illumina and VWR International Sign Agreement
Integrated DNA Technologies Collaborates with RainDance Technologies
Life Technologies Takes Over Compendia Bioscience
Luminex Takes Over GenturaDx
Life Technologies Takes Over Pinpoint Genomics
Idaho Technology Announces Corporate Rebranding to BioFire Diagnostics
Exosome Diagnostics and Life Technologies Ink Agreement
Abbott Inks Partnership Agreement with Astellas Pharma Global Development for Executing Clinical Trial on TransVax™ Vaccine
Accelero Bioanalytics and Synlab Clinical Trial Enter into Collaboration
Immunexpress Group, Biocartis and Debiopharm Ink Agreement to Develop and Commercialze SeptiCyte® Triage Assay
Accelero Bioanalytics Collaborates with LPT Laboratory

9. FOCUS ON SELECT GLOBAL PLAYERS
Agilent Technologies, Inc. (US)
Becton, Dickinson and Company (US)
BioFire Diagnostics, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Cepheid (US)
Eppendorf AG (Germany)
Exiqon A/S (Denmark)
F. Hoffmann-La Roche Ltd. (Switzerland)
Fluidigm Corporation (US)
Illumina, Inc. (US)
Promega Corporation (US)
RainDance Technologies, Inc. (US)
QIAGEN N.V. (Netherlands)
Takara Bio, Inc. (Japan)
Thermo Fisher Scientific Inc. (US)

10. GLOBAL MARKET PERSPECTIVE
Table 24: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 25: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 26: World 12-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 27: World Recent Past, Current & Future Analysis for qPCR and dPCR Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 28: World Historic Review for qPCR and dPCR Reagents by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 29: World 12-Year Perspective for qPCR and dPCR Reagents by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 30: World Recent Past, Current & Future Analysis for qPCR and dPCR Instruments by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 31: World Historic Review for qPCR and dPCR Instrumentation by Geographic Region
US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 32: World 12-Year Perspective for qPCR and dPCR Instruments by Geographic Region
Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 33: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Product Segment
qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 34: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Product Segment
qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 35: World 12-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Product Segment
Percentage Breakdown of Revenues for qPCR and dPCR Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 36: World Recent Past, Current & Future Analysis for qPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 37: World Historic Review for qPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 38: World 12-Year Perspective for qPCR Instrumentation and Reagents by Product Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 39: World Recent Past, Current & Future Analysis for dPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 40: World Historic Review for dPCR Instrumentation and Reagents by Product Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 41: World 12-Year Perspective for dPCR Instrumentation and Reagents by Product Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 42: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by End-Use Segment
Educational/ Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 43: World Historic Review for qPCR and dPCR Instrumentation and Reagents by End-Use Segment
Educational/Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 44: World 12-Year Perspective for qPCR and dPCR Instrumentation by End-Use Segment
Percentage Breakdown of Revenues for Educational/ Research, Testing Laboratories and Pharma Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES
A.Market Analysis
Current and Future Analysis
qPCR Vs. dPCR Instrumentation is the US
Cancer Stats
Table 45: New Cancer Cases in the US by Gender and Affected Site: 2014
Table 46: New Cancer Cases in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
Table 47: New Cancer Cases in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
Table 48: New Cancer Cases in US by State: 2014
Table 49: The US Cancer Incidence for All Body Sites by Gender & Age Group (2013): New Cancer Cases for Males & Females for the Age groups Under 45 years; 45 years and Above; Under 65 years; and 65 years and Above (includes corresponding Graph/Chart)
Cancer Mortality Statistics
Table 50: Cancer Related Deaths in the US by Gender and Body Site: 2014
Table 51: Cancer Related Deaths in Males in US by Leading Site: 2014 (includes corresponding Graph/Chart)
Table 52: Cancer Related Deaths in Females in US by Leading Site: 2014 (includes corresponding Graph/Chart)
Table 53: Number of Deaths Related to Major Types of Cancer in US by State: 2014
Competition
Product Introductions
Strategic Corporate Developments
Select Key Players
B.Market Analytics
Table 54: The US Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 55: The US Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 56: The US 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2013 & 2018 (includes corresponding Graph/Chart)

2. CANADA
A.Market Analysis
Current and Future Analysis
Cancer Statistics in Canada
Table 57: New Cancer Cases in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 58: New Cancer Cases in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 59: New Cancer Cases in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Table 60: Cancer Related Deaths in Canada by Gender and Affected Site: 2014 (includes corresponding Graph/Chart)
Table 61: Cancer Related Deaths in Canada by Province: 2014 (includes corresponding Graph/Chart)
Table 62: Cancer Related Deaths in Canada by Age Group: 2014 (includes corresponding Graph/Chart)
Funglyn Biotech, Inc.
A Key Player
B.Market Analytics
Table 63: Canadian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 64: Canadian Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 65: Canadian 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

3. JAPAN
A.Market Analysis
Current and Future Analysis
Table 66: Cancer Related Deaths by Age Group: 2013 (includes corresponding Graph/Chart)
Takara Bio, Inc.
A Key Player
B.Market Analytics
Table 67: Japanese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 68: Japanese Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 69: Japanese 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

4. EUROPE
A.Market Analysis
Current and Future Analysis
PCR Reagents in Europe: An Overview
Cancer Stats
Table 70: Cancer Incidence in Europe by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
Table 71: Number of New Cancer Cases in Europe (2012-2030) (in Million) (includes corresponding Graph/Chart)
B.Market Analytics
Table 72: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 73: European Historic Review for qPCR and dPCR Instrumentation by Geographic Region
France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 74: European 12-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region
Percentage Breakdown of Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 75: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 76: European Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 77: European 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
4a. FRANCE
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 78: French Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 79: French Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 80: French 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
4b. GERMANY
A.Market Analysis
Current and Future Analysis
Product Introduction
Strategic Corporate Developments
Eppendorf AG
A Key German Player
B.Market Analytics
Table 81: German Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 82: German Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 83: German 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
4c. ITALY
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 84: Italian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 85: Italian Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 86: Italian 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
4d. THE UNITED KINGDOM
A.Market Analysis
Current and Future Analysis
Product Introductions
Strategic Corporate Development
B.Market Analytics
Table 87: The UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 88: The UK Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 89: The UK 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
4e. REST OF EUROPE
A.Market Analysis
Current And Future Analysis
Product Introductions
Strategic Corporate Developments
Key Players
B.Market Analytics
Table 90: Rest of European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 91: Rest of European Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 92: Rest of European 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 93: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region
China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 94: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Geographic Region
China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 95: Asia-Pacific 12-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region
Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
Table 96: Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2018 (includes corresponding Graph/Chart)
Table 97: Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 98: Asia-Pacific 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 99: Chinese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 100: Chinese Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 101: Chinese 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)
5b. REST OF ASIA-PACIFIC
A.Market Analysis
Current And Future Analysis
Strategic Corporate Development
Professional Biotech Pvt. Ltd.
A Key Real Time PCR Manufacturer In India
B.Market Analytics
Table 102: Rest of Asia-Pacific Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 103: Rest of Asia-Pacific Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 104: Rest of Asia-Pacific US 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

6. MIDDLE EAST & AFRICA
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 105: The Middle East Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 106: The Middle East Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 107: The Middle East 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

7. LATIN AMERICA
A.Market Analysis
Current and Future Analysis
B.Market Analytics
Table 108: Latin American Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2013 through 2020 (includes corresponding Graph/Chart)
Table 109: Latin American Historic Review for qPCR and dPCR Instrumentation by Category
Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2009 through 2012 (includes corresponding Graph/Chart)
Table 110: Latin American 12-Year Perspective for qPCR and dPCR Instrumentation by Category
Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2009, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 41 (including Divisions/Subsidiaries (44)
The United States (26)
Canada (1)
Japan (1)
Europe (15)
Germany (5)
The United Kingdom (2)
Spain (1)
Rest of Europe (7)
Asia-Pacific (Excluding Japan) (1)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

STILLE Surgical Instruments Alcon Incorporated Hoya Surgical Optics, Inc. Hollister Inc. PerkinElmer, Inc. Cyberonics, Inc.